Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 203100

STRIBILD (COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE)
150MG;150MG;200MG;300MG Marketing Status: Prescription

Active Ingredient: COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: STRIBILD
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG;150MG;200MG;300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N203100
Product Number: 001
Approval Date: Aug 27, 2012
Applicant Holder Full Name: GILEAD SCIENCES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English